1910 Genetics: Funding, Investors & Team (Oct 2026)
1910 Genetics is a biotechnology company that uses AI and laboratory automation to advance drug discovery for both small and large molecules. We combine AI with three different types of data to create new drug candidates and software solutions for pharmaceutical and tech companies. Our focus is on developing treatments for neurological, autoimmune diseases, and cancer. We have received backing from top investors such as M12 (Microsoft's Venture Fund), Playground Global, Sam Altman, Y Combinator, and FoundersX Ventures.
1910 Genetics has raised $22.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Oct 2024.
1910 Genetics Company Profile and Key Stats
Latest funding round on record: Oct 2024.
1910 Genetics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
1910 Genetics raised $22.0M in a Series A announced in Mar 2021.
3.6 years later, an undisclosed round was announced in Oct 2024 with no disclosed amount.
1910 Genetics Founders and Leadership Team
Contact details for the 1910 Genetics team: 1 of 1 has an email address on file.
Start 14-day free trial →1910 Genetics Funding Compared to Other Artificial Intelligence Startups
Funded Startups Like 1910 Genetics in Artificial Intelligence and Boston
Companies Similar to 1910 Genetics
Sirona Medical Inc. is addressing the needs of today’s radiology practices with a novel cloud-native platform…
Leading health plans, program providers, and over 100 communities across the U.S., rely on CredibleMind to…
RapidCanvas is an AI platform that combines the precision and automation of AI agents with the deep domain…
Labelbox is a collaborative data training platform that creates and manages labeled data for machine learning…
Clueso is an AI-driven support system for SaaS applications.
Dapta is a software-as-a-service company that provides a platform with minimal coding required to create APIs…
Factored was co-founded with renowned AI expert Andrew Ng (Stanford/AI Fund/Google Brain/Coursera) and…
Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor…
Lightsprint provides an AI-native product development platform that supports collaborative software…
Suki is a leading technology company that provides AI-powered voice solutions for healthcare. Its mission is…
Drylab is an AI-powered bioinformatics platform for biomedical data analysis, research workflows, and…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
1910 Genetics Funding FAQs
What does 1910 Genetics do?
1910 Genetics is a biotechnology company that uses AI and laboratory automation to advance drug discovery for both small and large molecules. We combine AI with three different types of data to create new drug candidates and software solutions for pharmaceutical and tech companies. Our focus is on developing treatments for neurological, autoimmune diseases, and cancer. We have received backing from top investors such as M12 (Microsoft's Venture Fund), Playground Global, Sam Altman, Y Combinator, and FoundersX Ventures.
How much funding has 1910 Genetics raised?
1910 Genetics has raised $22.0M across 2 rounds on record.
When did 1910 Genetics last raise funding?
1910 Genetics' most recent funding round on record was announced in Oct 2024. The amount was not disclosed.
Who founded 1910 Genetics?
FundedIQ lists Jen Nwankwo (Founder) at 1910 Genetics.
Where is 1910 Genetics headquartered?
1910 Genetics is based in Boston, Massachusetts, United States.
How many employees does 1910 Genetics have?
1910 Genetics is in the 11-50 employee band.
About FundedIQ's 1910 Genetics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 1910 Genetics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.